Xeris Biopharma Holdings (XERS) Gross Margin (2020 - 2026)
Xeris Biopharma Holdings' Gross Margin came in at 86.41% for Q2 2026, up 3.05 percentage points from 83.37% a year earlier but down 0.86 percentage points from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Gross Margin (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Xeris Biopharma Holdings reported Gross Margin of 86.58%, up 4.34 percentage points year-over-year; for FY2025, it was 85.41%, up 3.55 percentage points from FY2024.
- Gross Margin carries a five-year change of +31.06 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 81.86% in FY2024 (-0.66 pp), 82.52% in FY2023 (+3.05 pp), 79.47% in FY2022 (+6.33 pp) and 73.14% in FY2021 (+18.79 pp).
- The five-year range for quarterly Gross Margin is 70.89% (Q3 2021) to 87.28% (Q1 2026).
- Year-over-year, Gross Margin has increased for four consecutive quarters, with an average year-over-year change of +1.38 percentage points over the last eight quarters.
- The fastest year-over-year change in Gross Margin over five years came in Q4 2021 (a gain of 23.63 percentage points), and the weakest in Q3 2024 (a drop of 8.08 percentage points).
- Business Quant data shows XERS's Gross Margin at 87.28% (Q1 2026), 87.24% (Q4 2025) and 85.22% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Xeris Biopharma Holdings | 1.71 Bn | 1.27 Bn | 79.59 Mn | 86.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.41% |
| Mar 31, 2026 | 87.28% |
| Dec 31, 2025 | 87.24% |
| Sep 30, 2025 | 85.22% |
| Jun 30, 2025 | 83.37% |
| Mar 31, 2025 | 85.48% |
| Dec 31, 2024 | 84.23% |
| Sep 30, 2024 | 74.95% |
| Jun 30, 2024 | 83.79% |
| Mar 31, 2024 | 85.31% |
| Dec 31, 2023 | 82.95% |
| Sep 30, 2023 | 83.03% |
| Jun 30, 2023 | 80.12% |
| Mar 31, 2023 | 83.98% |
| Dec 31, 2022 | 81.02% |
| Sep 30, 2022 | 82.30% |
| Jun 30, 2022 | 80.99% |
| Mar 31, 2022 | 71.58% |
| Dec 31, 2021 | 77.19% |
| Sep 30, 2021 | 70.89% |
API Access
Xeris Biopharma Holdings Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();